Sanara MedTech Inc. SMTI Debt - Unamortized Discount (Premium) and Issuance Costs, Net
Debt - Unamortized Discount (Premium) and Issuance Costs, Net at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredFinanceCostsNet.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s debt - unamortized discount (premium) and issuance costs, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sanara MedTech Inc.'s debt - unamortized discount (premium) and issuance costs, net?
- Sanara MedTech Inc. (SMTI) reported debt - unamortized discount (premium) and issuance costs, net of $882.5K in Q1 2026.
- How has Sanara MedTech Inc.'s debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
- Sanara MedTech Inc.'s debt - unamortized discount (premium) and issuance costs, net decreased by 22.1% year-over-year, from $1.13M to $882.5K.
- What is the long-term trend for Sanara MedTech Inc.'s debt - unamortized discount (premium) and issuance costs, net?
- Over 2 years (2023 to 2025), Sanara MedTech Inc.'s debt - unamortized discount (premium) and issuance costs, net has grown at a 311.3% compound annual growth rate (CAGR), from $56.52K to $956.04K.
- What does debt - unamortized discount (premium) and issuance costs, net mean?
- This represents the net adjustment to the face value of debt, accounting for original issue discounts, premiums, and capitalized debt issuance costs. These amounts are amortized over the life of the debt instrument to reflect the effective interest rate. It is essential for reconciling the carrying value of debt to its face value.